As our mission is trans-disciplinary, we have developed the program to reflect our collaborative efforts. In addition to the three symposia we will have a presentation on circulating tumor DNA. A talented and diverse Program Committee has been charged with making all of the sessions dynamic, relevant and interactive.
While hemangioendothelioma is the chosen "Sarcoma of the Year," there will be several other
plenary sessions focused on different tumor types hoping to encourage the submission of
abstracts across collaborative disciplines.